Clinical Significance of Tie-2-Expressing Monocytes/Macrophages and Angiopoietins in the Progression of Ovarian Cancer-State-of-the-Art.
Wiktoria SkibaDorota SuszczykAnna Pawłowska-ŁachutKarolina WłodarczykAnna PańczyszynIwona WertelPublished in: Cells (2022)
Tumour growth and metastasis are specific to advanced stages of epithelial ovarian cancer (EOC). Tumour angiogenesis is an essential part of these processes. It is responsible for providing tumours with nutrients, metabolites, and cytokines and facilitates tumour and immune cell relocation. Destabilised vasculature, a distinctive feature of tumours, is also responsible for compromising drug delivery into the bulk. Angiogenesis is a complex process that largely depends on how the tumour microenvironment (TME) is composed and how a specific organ is formed. There are contrary reports on whether Tie-2-expressing monocytes/macrophages (TEMs) reported as the proangiogenic population of monocytes have any impact on tumour development. The aim of this paper is to summarise knowledge about ovarian-cancer-specific angiogenesis and the unique role of Tie-2-expressing monocytes/macrophages in this process. The significance of this cell subpopulation for the pathophysiology of EOC remains to be investigated.
Keyphrases
- drug delivery
- endothelial cells
- dendritic cells
- peripheral blood
- vascular endothelial growth factor
- healthcare
- stem cells
- ms ms
- emergency department
- wound healing
- single cell
- heavy metals
- cancer therapy
- immune response
- bone marrow
- high resolution
- mesenchymal stem cells
- risk assessment
- atomic force microscopy
- neural network